We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$414M
AUM Growth
+$32.3M
(+8.5%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
30.48%
Holding
216
New
11
Increased
89
Reduced
59
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.36M |
| 2 |
NOV
NOV
|
+$1.18M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$936K |
| 4 |
Visa
V
|
+$812K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$805K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$501K |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$380K |
| 3 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$326K |
| 4 |
Liberty Global Class A
LBTYA
|
+$282K |
| 5 |
Biogen
BIIB
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.03% |
| 2 | Miscellaneous | 15.33% |
| 3 | Financials | 12.38% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETM
51
DELISTED
PETSMART INC
PETM
| $1.57M | 0.38% |
22,760
+5,150
| +29% | +$341K |
|
52
APA Corp
APA
$14.9B
| $1.52M | 0.37% |
18,382
-28
| -0.2% | -$2.3K |
|
53
Meta Platforms (Facebook)
META
$1.47T
| $1.52M | 0.37% |
25,250
-100
| -0.4% | -$6.34K |
|
54
Union Pacific
UNP
$183B
| $1.41M | 0.34% |
15,038
-650
| -4% | -$57.7K |
|
55
SPDR Gold Trust
GLD
$149B
| $1.4M | 0.34% |
11,325
| – | – |
|
56
Baxter International
BAX
$13.5B
| $1.4M | 0.34% |
34,992
+5,247
| +18% | +$196K |
|
57
Duke Energy
DUK
$93.8B
| $1.39M | 0.34% |
19,546
+50
| +0.3% | +$3.48K |
|
58
Newmont
NEM
$135B
| $1.39M | 0.33% |
59,159
-3,773
| -6% | -$89.8K |
|
59
General Mills
GIS
$22.2B
| $1.36M | 0.33% |
26,254
-3,100
| -11% | -$153K |
|
60
Dominion Energy
D
$57.7B
| $1.36M | 0.33% |
19,130
+228
| +1% | +$15.6K |
|
61
Globe Life
GL
$13.3B
| $1.36M | 0.33% |
25,875
| – | – |
|
62
Williams Companies
WMB
$90.2B
| $1.34M | 0.32% |
32,915
+8,295
| +34% | +$336K |
|
63
AbbVie
ABBV
$451B
| $1.25M | 0.3% |
24,264
-525
| -2% | -$26.5K |
|
64
Canadian Pacific Kansas City
CP
$82.7B
| $1.24M | 0.3% |
41,300
-1,075
| -3% | -$32.6K |
|
|
GG
65
DELISTED
Goldcorp Inc
GG
| $1.24M | 0.3% |
50,523
+25,958
| +106% | +$660K |
|
|
66
Philip Morris
PM
$299B
| $1.23M | 0.3% |
15,060
-6,207
| -29% | -$501K |
|
67
McCormick & Company Non-Voting
MKC
$14.9B
| $1.21M | 0.29% |
33,856
| – | – |
|
68
iShares Russell 2000 ETF
IWM
$80.8B
| $1.2M | 0.29% |
10,282
+20
| +0.2% | +$2.31K |
|
69
Zimmer Biomet
ZBH
$19.2B
| $1.19M | 0.29% |
12,965
-154
| -1% | -$14.2K |
|
|
MWR.CL
70
DELISTED
MORGAN STANLEY CAPITAL TRUST III
MWR.CL
| $1.17M | 0.28% |
46,650
+17,660
| +61% | +$437K |
|
71
RTX Corp
RTX
$285B
| $1.17M | 0.28% |
15,915
+2,655
| +20% | +$191K |
|
72
AT&T
T
$178B
| $1.17M | 0.28% |
44,126
+952
| +2% | +$23.9K |
|
73
Walt Disney
DIS
$187B
| $1.15M | 0.28% |
14,305
+550
| +4% | +$42.6K |
|
|
MER.PRD
74
DELISTED
MERRILL PF CP TST III 7%
MER.PRD
| $1.11M | 0.27% |
43,800
| – | – |
|
75
McDonald's
MCD
$188B
| $1.06M | 0.26% |
10,867
+1,161
| +12% | +$111K |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, M&R Capital Management held 216 positions worth $414M, up 8.5% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&R Capital Management deployed $27.9M of net new capital in Q1 2014, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $501K trimmed.
- M&R Capital Management's largest Q1 2014 buy was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
- M&R Capital Management added most to Allergan plc in Q1 2014, an estimated $8.36M increase.
- M&R Capital Management's biggest Q1 2014 reduction was Philip Morris, cutting an estimated $501K.
- M&R Capital Management fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $380K.
- M&R Capital Management's ten largest holdings make up 30% of its $414M portfolio in Q1 2014.
- M&R Capital Management opened 11 new positions and closed 8 in Q1 2014.
- M&R Capital Management's portfolio value rose 8.5% quarter-over-quarter to $414M.
Based on M&R Capital Management's 13F filing for Q1 2014, filed 2 May 2014.